The company operates an equity based share option scheme to certain employees and board members which provides additional remuneration for those who are key to the company. The options are granted under an approved EMI and unapproved option plan, with the exercise price of £2.52, £1.38, £0.239 or £0.00001. The options expire ten years after the date of the grant. Option holders are not entitled to dividends until the shares are exercised. All EMI options granted have performance conditions relating to the relevant employee remaining in the employment of the company at exercise.
A reconciliation of share option movements during the year ended 31 December 2025 is shown below:
Number of options - Weighted average exercise price
Outstanding as at 1 January 2025: 61,218 - £1.17 (2024: 41,967 - £0.14)
Granted during the year: 497,755 - £0.09 (2024: 26,751 - £2.52)
Forfeited during the year: (12,372) - (£2.52) (2024: Nil - £Nil)
Exercised during the year: Nil - £Nil (2024: (7500) - (£0.24))
Outstanding as at 31 December 2025: 546,601 - £0.15 (2024: 61,218 - £1.17)
Equity settled schemes - charges arising: £467,593 (2024: £49,340)